Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and meta-analysis.
作者： Andreas Fontalis , Eustathios Kenanidis , Efthymia Prousali , Michael Potoupnis , Eleftherios Tsiridis
DOI: 10.1080/14740338.2018.1430764
关键词:
摘要: ABSTRACTIntroduction: Denosumab is a monoclonal antibody that received approval by the FDA for treatment of osteoporosis in 2010. Available higher level research evidence concerns treatment...
sci-hub.se 参考文章(53)
Pingal A. Desai, Parth A. Vyas, Joseph M. Lane, Atypical femoral fractures: a review of the literature. Current Osteoporosis Reports. ,vol. 11, pp. 179- 187 ,(2013) , 10.1007/S11914-013-0167-Y
Julian PT Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savović, Kenneth F Schulz, Laura Weeks, Jonathan AC Sterne, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials BMJ. ,vol. 343, ,(2011) , 10.1136/BMJ.D5928
A. D. Anastasilakis, S. A. Polyzos, A. Gkiomisi, Z. G. Saridakis, D. Digkas, I. Bisbinas, G. T. Sakellariou, A. Papatheodorou, P. Kokkoris, P. Makras, Denosumab versus zoledronic acid in patients previously treated with zoledronic acid. Osteoporosis International. ,vol. 26, pp. 2521- 2527 ,(2015) , 10.1007/S00198-015-3174-2
Jaap W. Mandema, Jenny Zheng, Cesar Libanati, Juan Jose Perez Ruixo, Time Course of Bone Mineral Density Changes With Denosumab Compared With Other Drugs in Postmenopausal Osteoporosis: A Dose-Response–Based Meta-Analysis The Journal of Clinical Endocrinology and Metabolism. ,vol. 99, pp. 3746- 3755 ,(2014) , 10.1210/JC.2013-3795
Athanasios D. Anastasilakis, Stergios A. Polyzos, Zoe A. Efstathiadou, Matthaios Savvidis, Grigorios T. Sakellariou, Athanasios Papatheodorou, Panagiotis Kokkoris, Polyzois Makras, Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers. Metabolism-clinical and Experimental. ,vol. 64, pp. 1291- 1297 ,(2015) , 10.1016/J.METABOL.2015.06.018
J. C. Netelenbos, P. P. Geusens, G. Ypma, S. J. E. Buijs, Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands Osteoporosis International. ,vol. 22, pp. 1537- 1546 ,(2011) , 10.1007/S00198-010-1372-5
David L Kendler, Christian Roux, Claude Laurent Benhamou, Jacques P Brown, Michael Lillestol, Suresh Siddhanti, Hoi-Shen Man, Javier San Martin, Henry G Bone, Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy Journal of Bone and Mineral Research. ,vol. 25, pp. 72- 81 ,(2010) , 10.1359/JBMR.090716
J. A. C. Sterne, A. J. Sutton, J. P. A. Ioannidis, N. Terrin, D. R. Jones, J. Lau, J. Carpenter, G. Rucker, R. M. Harbord, C. H. Schmid, J. Tetzlaff, J. J. Deeks, J. Peters, P. Macaskill, G. Schwarzer, S. Duval, D. G. Altman, D. Moher, J. P. T. Higgins, Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials BMJ. ,vol. 343, ,(2011) , 10.1136/BMJ.D4002
C Roux, LC Hofbauer, PR Ho, JD Wark, MC Zillikens, A Fahrleitner-Pammer, F Hawkins, M Micaelo, Salvatore Minisola, N Papaioannou, M Stone, I Ferreira, S Siddhanti, RB Wagman, JP Brown, None, Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study Bone. ,vol. 58, pp. 48- 54 ,(2014) , 10.1016/J.BONE.2013.10.006
Stavros C. Manolagas, Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews. ,vol. 21, pp. 115- 137 ,(2000) , 10.1210/EDRV.21.2.0395